share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券

美股sec公告 ·  02/20 10:58
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired by Altshuler on 02/17/2024, through restricted stock vesting and performance shares, both as part of compensation from the issuer. This transaction follows a previous sale of 3,145 shares by Altshuler on 02/12/2024, which grossed $1,321,654.80. The notice for the upcoming sale was filed on the same day as the planned sale, with the plan for this transaction having been adopted on 05/10/2023.
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired by Altshuler on 02/17/2024, through restricted stock vesting and performance shares, both as part of compensation from the issuer. This transaction follows a previous sale of 3,145 shares by Altshuler on 02/12/2024, which grossed $1,321,654.80. The notice for the upcoming sale was filed on the same day as the planned sale, with the plan for this transaction having been adopted on 05/10/2023.
Vertex Pharmicals Inc.高管戴維·阿爾特舒勒定於2024年2月20日出售4,002股普通股，總市值約爲1,684,001.58美元。Altshuler最近於2024年2月17日通過限制性股票歸屬和績效股票收購了待出售的股票，這兩者都是發行人薪酬的一部分。該交易是在Altshuler此前於2024年12月2日出售3,145股股票之後進行的，總收入爲1,321,654.80美元。即將進行的出售通知與計劃出售的同一天提交，該交易的計劃已於2023年10月5日通過。
Vertex Pharmicals Inc.高管戴維·阿爾特舒勒定於2024年2月20日出售4,002股普通股，總市值約爲1,684,001.58美元。Altshuler最近於2024年2月17日通過限制性股票歸屬和績效股票收購了待出售的股票，這兩者都是發行人薪酬的一部分。該交易是在Altshuler此前於2024年12月2日出售3,145股股票之後進行的，總收入爲1,321,654.80美元。即將進行的出售通知與計劃出售的同一天提交，該交易的計劃已於2023年10月5日通過。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息